AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Erenumab in South Africa
2 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| PASURTA 140 mg/ml | 54/7.3/0588 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| PASURTA 70 mg/ml | 54/7.3/0587 | Novartis South Africa (Pty) Ltd | active | 1 Jan 1900 |
Erenumab — SAHPRA Registration Details
SAHPRA (South Africa) has 2 registered products containing Erenumab, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Erenumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.